NCT05128617View on ClinicalTrials.gov

Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions

Breast Cancer

Interventions

DRUG

Epirubicin-cyclophosphamide

1 cycle of Epirubicin-cyclophosphamide

DRUG

Paclitaxel

1 cycle of Paclitaxel

Trial Locations (1)

67033

Institut de Cancerologie Strasbourg Europe, Strasbourg

All Listed Sponsors

collaborator

Université de Strasbourg - Unité de Recherche 3072 - Mitochondries, Stress oxydant, Protection musculaire

UNKNOWN

lead

Institut de cancérologie Strasbourg Europe

OTHER

NCT05128617 - Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study | Biotech Hunter | Biotech Hunter